Ahmed Badawi, MD
Dermatology · Joplin, MONPI 1417319971
Payments from drug & device makers
Across 33 payments — averaging $214.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- Blueprint Medicines Corporation$3K
- AbbVie$308
- Lilly USA, LLC$108
- Eli Lilly$99
- Johnson & Johnson$81
- plus $259 from 6 others
What the payments were for
- Consulting fees$5,94984%
- Food & beverage$1,00714%
- Education$1382%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 2 | $3,423 |
| Blueprint Medicines Corporation | 3 | $2,815 |
| AbbVie(2 entities) | 8 | $308 |
| Lilly USA, LLC | 6 | $108 |
| Eli Lilly | 1 | $99 |
| Johnson & Johnson | 4 | $81 |
| Abbott | 1 | $73 |
| Incyte Corporation | 2 | $53 |
| Kyowa Kirin, Inc. | 2 | $51 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,094 in reported general payments places this provider in the 65th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 119 | $471,222 |
| OtezlaApremilast | 64 | $315,086 |
| AdbryTralokinumab-Ldrm | 11 | $39,696 |
| Clobetasol Propionate | 262 | $14,848 |
| Acitretin | 38 | $9,084 |
| Tacrolimus | 34 | $4,618 |
| Fluorouracil | 42 | $3,868 |
| Triamcinolone Acetonide | 201 | $3,412 |
| Ketoconazole | 173 | $2,552 |
| Metronidazole | 41 | $1,898 |
| Tretinoin | 18 | $1,628 |
| Dapsone | 37 | $1,611 |
| Clindamycin Phosphate | 39 | $1,571 |
| Colchicine | 13 | $1,204 |
| Imiquimod | 38 | $1,138 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Joplin
- Nathaniel PhelanJoplin$10K
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
- Jonathan CleaverKirksville$483K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.